CJC-1295 and Ipamorelin are synthetic peptides investigated for their interactions with distinct receptor systems involved in growth hormone signalling.
CJC-1295 is an analogue of growth hormone-releasing hormone (GHRH), designed to interact with GHRH receptors. Ipamorelin is a pentapeptide growth hormone secretagogue that interacts with the ghrelin receptor, also known as GHSR-1a.
Research involving these peptides examines receptor activation, intracellular signalling cascades and the molecular regulation of growth hormone-associated pathways.





